To compare the sensitivity and specificity of the AdenoPlus test with those of both viral cell culture with confirmatory immunofluorescence assay and polymerase chain reaction in detecting the ...
Please provide your email address to receive an email when new articles are posted on . Rapid Pathogen Screening has announced the restructuring of the North American licensing rights to the AdenoPlus ...
SAN DIEGO, CA--(Marketwired - May 16, 2017) - Quidel Corporation (QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Two articles published in the January issue of JAMA Ophthalmology (formerly Archives of Ophthalmology) describe 2 sensitive and specific point-of-care tests that can help clinicians quickly and easily ...
Please provide your email address to receive an email when new articles are posted on . Whoa. That happened fast. TearLab announced that it has received a CE mark for European marketing of a new point ...
Rapid Pathogen Screening (RPS) is taking back marketing rights specifically to eye care professionals in the U.S. and all medical professionals in Canada from Nicox to its AdenoPlus® adenoviral ...
A search of the Medicines and Healthcare Products Regulatory Agency website revealed no manufacturer Field Safety Notices or Medical Device Alerts for this device. No reports of adverse events were ...
SAN DIEGO, CA--(Marketwired - May 16, 2017) - Quidel Corporation (QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback